Phase 3 Sleep Disorders Trial, Recruiting NCT06681974 Sponsor: Instituto de Investigación Marqués de Valdecilla Condition: Sleep Disorders
Back to Sleep Disorders

Phase 3 Sleep Disorders Trial, Recruiting

NCT06681974
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with mild to moderate sleep apnoea (a condition where breathing repeatedly stops and starts during sleep) that does not meet the guidelines for treatment with a CPAP machine or a special dental device (called a mandibular advancement device)
  • People who were offered a CPAP machine or dental device but declined or were not considered suitable candidates for those treatments
  • People aged between 18 and 70 years
  • People who have read, understood, and signed the consent form agreeing to take part

Who may not be able to join:

  • People with structural differences in the shape of their skull or face from birth or development
  • People with a severe intellectual disability or significant developmental delay
  • People who have been diagnosed with a neurodegenerative disease (a condition where parts of the nervous system progressively stop working, such as Parkinson's disease)
  • People who have limited movement of the tongue, a condition where the tongue is tethered to the floor of the mouth (tongue-tie), or a jaw joint disorder
  • People who regularly take sleeping tablets or similar medications
  • People with conditions affecting the muscles used for swallowing or speaking (bulbar pathologies)
  • People whose sleep apnoea events are caused by the brain rather than a physical blockage, accounting for more than half of all events during the night
  • People with obesity classified as Grade II or higher (confirm with trial site for the specific measurement used)
  • People with serious heart, lung, or neuromuscular conditions, those who require oxygen at home, or those with a condition combining obesity and poor breathing during sleep (obesity hypoventilation syndrome)
  • People who decline to participate even though all other criteria are met

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Instituto de Investigación Marqués de Valdecilla
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
1 May 2024

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

the effectiveness of Oropharyngeal myofunctional therapy in the treatment of Obstructive Sleep Apnea compared to conservative treatment measured by Respiratory Poligraphy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov